CIPC
gene geneOn this page
Summary
CIPC (CLOCK interacting pacemaker, HGNC:20365) is a protein-coding gene on chromosome 14q24.3, encoding CLOCK-interacting pacemaker (Q9C0C6). Transcriptional repressor which may act as a negative-feedback regulator of CLOCK-BMAL1 transcriptional activity in the circadian-clock mechanism.
Predicted to be involved in negative regulation of DNA-templated transcription and negative regulation of circadian rhythm. Located in cytosol; nucleolus; and nucleoplasm.
Source: NCBI Gene 85457 — RefSeq curated summary.
At a glance
- GWAS associations: 3
- Clinical variants (ClinVar): 61 total
- MANE Select transcript:
NM_033426
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:20365 |
| Approved symbol | CIPC |
| Name | CLOCK interacting pacemaker |
| Location | 14q24.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000198894 |
| Ensembl biotype | protein_coding |
| OMIM | 616995 |
| Entrez | 85457 |
Gene structure
Transcript identifiers
Ensembl transcripts: 22 — 21 protein_coding, 1 retained_intron
ENST00000361786, ENST00000554447, ENST00000554658, ENST00000555200, ENST00000555437, ENST00000555611, ENST00000556863, ENST00000557115, ENST00000880022, ENST00000880023, ENST00000880024, ENST00000880025, ENST00000880026, ENST00000880027, ENST00000880028, ENST00000880029, ENST00000930386, ENST00000930387, ENST00000971302, ENST00000971303, ENST00000971304, ENST00000971305
RefSeq mRNA: 1 — MANE Select: NM_033426
NM_033426
CCDS: CCDS9855
Canonical transcript exons
ENST00000361786 — 4 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000911977 | 77109812 | 77109981 |
| ENSE00000941065 | 77113425 | 77117287 |
| ENSE00001240307 | 77098258 | 77098361 |
| ENSE00003529256 | 77105657 | 77105844 |
Expression profiles
Bgee: expression breadth ubiquitous, 254 present calls, max score 97.84.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 17.0827 / max 215.5820, expressed in 1795 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 140756 | 16.9088 | 1794 |
| 140757 | 0.1739 | 70 |
Top tissues by expression
256 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| skeletal muscle tissue of rectus abdominis | UBERON:0004511 | 97.84 | gold quality |
| quadriceps femoris | UBERON:0001377 | 97.73 | gold quality |
| vastus lateralis | UBERON:0001379 | 97.69 | gold quality |
| tibialis anterior | UBERON:0001385 | 97.33 | gold quality |
| deltoid | UBERON:0001476 | 97.25 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 97.19 | gold quality |
| left ventricle myocardium | UBERON:0006566 | 96.61 | gold quality |
| biceps brachii | UBERON:0001507 | 96.55 | gold quality |
| skeletal muscle tissue of biceps brachii | UBERON:0004502 | 96.44 | gold quality |
| gastrocnemius | UBERON:0001388 | 96.07 | gold quality |
| muscle tissue | UBERON:0002385 | 96.05 | gold quality |
| cardiac muscle of right atrium | UBERON:0003379 | 95.62 | gold quality |
| muscle of leg | UBERON:0001383 | 95.54 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 95.36 | gold quality |
| upper arm skin | UBERON:0004263 | 94.82 | gold quality |
| bronchial epithelial cell | CL:0002328 | 94.71 | gold quality |
| bronchus | UBERON:0002185 | 94.09 | gold quality |
| lateral globus pallidus | UBERON:0002476 | 94.00 | gold quality |
| corpus callosum | UBERON:0002336 | 93.84 | gold quality |
| globus pallidus | UBERON:0001875 | 93.78 | gold quality |
| inferior vagus X ganglion | UBERON:0005363 | 93.75 | gold quality |
| medial globus pallidus | UBERON:0002477 | 93.74 | gold quality |
| myocardium | UBERON:0002349 | 93.48 | gold quality |
| lateral nuclear group of thalamus | UBERON:0002736 | 93.44 | gold quality |
| subthalamic nucleus | UBERON:0001906 | 93.40 | gold quality |
| mucosa of paranasal sinus | UBERON:0005030 | 93.38 | gold quality |
| dorsal plus ventral thalamus | UBERON:0001897 | 93.35 | gold quality |
| superior vestibular nucleus | UBERON:0007227 | 93.34 | gold quality |
| cerebellum | UBERON:0002037 | 93.19 | gold quality |
| cerebellar cortex | UBERON:0002129 | 93.09 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 4.74 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
171 targeting CIPC, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-3613-3P | 100.00 | 76.36 | 7965 |
| HSA-MIR-4481 | 100.00 | 66.42 | 1669 |
| HSA-MIR-450A-1-3P | 100.00 | 69.33 | 1837 |
| HSA-MIR-1252-5P | 100.00 | 69.80 | 2774 |
| HSA-MIR-6833-3P | 100.00 | 70.63 | 3197 |
| HSA-MIR-513A-5P | 100.00 | 69.77 | 2465 |
| HSA-MIR-5011-5P | 100.00 | 83.46 | 5820 |
| HSA-MIR-4768-5P | 100.00 | 69.49 | 2861 |
| HSA-MIR-371B-5P | 99.99 | 75.34 | 4759 |
| HSA-MIR-186-5P | 99.99 | 70.83 | 3707 |
| HSA-MIR-548C-3P | 99.99 | 74.01 | 7587 |
| HSA-MIR-4282 | 99.99 | 75.36 | 6408 |
| HSA-MIR-27A-3P | 99.98 | 72.13 | 2955 |
| HSA-MIR-27B-3P | 99.98 | 72.13 | 2955 |
| HSA-MIR-9985 | 99.98 | 72.11 | 2939 |
| HSA-MIR-373-5P | 99.98 | 75.36 | 4753 |
| HSA-MIR-616-5P | 99.98 | 75.58 | 4775 |
| HSA-MIR-4745-5P | 99.98 | 65.95 | 1028 |
| HSA-MIR-1229-3P | 99.97 | 66.49 | 906 |
| HSA-MIR-3148 | 99.97 | 75.06 | 6478 |
| HSA-MIR-548AA | 99.96 | 70.64 | 3753 |
| HSA-MIR-548AP-3P | 99.96 | 70.64 | 3753 |
| HSA-MIR-548T-3P | 99.96 | 70.64 | 3753 |
| HSA-MIR-3605-5P | 99.96 | 67.12 | 932 |
| HSA-MIR-548AJ-3P | 99.96 | 73.38 | 5345 |
| HSA-MIR-548X-3P | 99.96 | 73.38 | 5345 |
| HSA-MIR-570-3P | 99.96 | 72.41 | 4910 |
| HSA-MIR-302E | 99.96 | 70.74 | 2669 |
| HSA-MIR-3658 | 99.96 | 73.87 | 4379 |
| HSA-MIR-590-3P | 99.96 | 74.34 | 6478 |
Literature-anchored findings (GeneRIF, showing 1)
- Since CAD and Erk have significant roles in cell proliferation and cell cycle, CIPC may work as a cell cycle regulator by interacting with these binding proteins. (PMID:26657846)
Cross-species orthologs
4 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | cipca | ENSDARG00000075397 |
| danio_rerio | cipcb | ENSDARG00000078095 |
| mus_musculus | Cipc | ENSMUSG00000034157 |
| rattus_norvegicus | Cipc | ENSRNOG00000011111 |
Protein
Protein identifiers
CLOCK-interacting pacemaker — Q9C0C6 (reviewed: Q9C0C6)
Alternative names: CLOCK-interacting circadian protein
All UniProt accessions (7): Q9C0C6, G3V310, G3V3Y7, G3V405, G3V4V0, G3V5J4, G3V5Y7
UniProt curated annotations — full annotation on UniProt →
Function. Transcriptional repressor which may act as a negative-feedback regulator of CLOCK-BMAL1 transcriptional activity in the circadian-clock mechanism. May stimulate BMAL1-dependent phosphorylation of CLOCK. However, the physiological relevance of these observations is unsure, since experiments in an animal model showed that CIPC is not critially required for basic circadian clock.
Subunit / interactions. Interacts with CLOCK. Forms a ternary complex with the CLOCK-BMAL1 heterodimer. Interacts with CAD and HSPA5.
Subcellular location. Nucleus. Cytoplasm. Cytosol.
RefSeq proteins (1): NP_219494* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR031602 | CIPC | Family |
Pfam: PF15800
UniProt features (13 total): region of interest 3, sequence variant 2, mutagenesis site 2, compositionally biased region 2, chain 1, coiled-coil region 1, short sequence motif 1, modified residue 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9C0C6-F1 | 58.88 | 0.16 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (1): 213
Mutagenesis-validated functional residues (2):
| Position | Phenotype |
|---|---|
| 186 | loss of predominant localization in the nucleus; when associated with a-187. no effect on cad- and hspa5-binding; when a |
| 187 | loss of predominant localization in the nucleus; when associated with a-186. no effect on cad- and hspa5-binding; when a |
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-9931510 | Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes |
MSigDB gene sets: 205 (showing top):
GSE45365_NK_CELL_VS_CD8A_DC_MCMV_INFECTION_DN, GSE18804_SPLEEN_MACROPHAGE_VS_TUMORAL_MACROPHAGE_UP, GOBP_CIRCADIAN_RHYTHM, RNGTGGGC_UNKNOWN, GCM_PTPRD, GOLDRATH_IMMUNE_MEMORY, TGACCTY_ERR1_Q2, SRF_Q5_01, GOBP_REGULATION_OF_CIRCADIAN_RHYTHM, chr14q24, NF1_Q6_01, WCTCNATGGY_UNKNOWN, USF_01, GGCKCATGS_UNKNOWN, ZHOU_INFLAMMATORY_RESPONSE_LIVE_DN
GO Biological Process (3): negative regulation of circadian rhythm (GO:0042754), negative regulation of DNA-templated transcription (GO:0045892), rhythmic process (GO:0048511)
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (5): nucleus (GO:0005634), nucleoplasm (GO:0005654), nucleolus (GO:0005730), cytosol (GO:0005829), cytoplasm (GO:0005737)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| Circadian clock | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular anatomical structure | 3 |
| nuclear lumen | 2 |
| circadian rhythm | 1 |
| regulation of circadian rhythm | 1 |
| negative regulation of biological process | 1 |
| DNA-templated transcription | 1 |
| regulation of DNA-templated transcription | 1 |
| negative regulation of RNA biosynthetic process | 1 |
| biological_process | 1 |
| binding | 1 |
| intracellular membrane-bounded organelle | 1 |
| intracellular membraneless organelle | 1 |
| cytoplasm | 1 |
| intracellular anatomical structure | 1 |
Protein interactions and networks
STRING
420 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| CIPC | CIART | Q8N365 | 530 |
| CIPC | NR1D2 | Q14995 | 505 |
| CIPC | ITGB1BP1 | O14713 | 439 |
| CIPC | BMAL2 | Q8WYA1 | 432 |
| CIPC | PER3 | P56645 | 411 |
| CIPC | BMAL1 | O00327 | 380 |
| CIPC | MSRA | Q9UJ68 | 373 |
| CIPC | PER2 | O15055 | 370 |
| CIPC | LIPC | P11150 | 370 |
| CIPC | E2F6 | O75461 | 347 |
| CIPC | NPAS2 | Q99743 | 345 |
| CIPC | CEBPD | P49716 | 344 |
| CIPC | RUNDC1 | Q96C34 | 319 |
| CIPC | RPS19 | P39019 | 316 |
| CIPC | CLOCK | O15516 | 307 |
IntAct
17 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| COPS5 | COPS2 | psi-mi:“MI:0914”(association) | 0.910 |
| BMAL2 | CLOCK | psi-mi:“MI:0914”(association) | 0.670 |
| CIPC | RABGEF1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| NCK2 | CIPC | psi-mi:“MI:0915”(physical association) | 0.560 |
| CIPC | CLOCK | psi-mi:“MI:0914”(association) | 0.530 |
| COPS5 | FBLL1 | psi-mi:“MI:0914”(association) | 0.350 |
| COPS5 | COPS2 | psi-mi:“MI:0914”(association) | 0.350 |
| NPAS2 | FHL2 | psi-mi:“MI:0914”(association) | 0.350 |
| CIPC | BMAL1 | psi-mi:“MI:0914”(association) | 0.350 |
| NCK2 | CIPC | psi-mi:“MI:0915”(physical association) | 0.000 |
| VPS26C | CIPC | psi-mi:“MI:0915”(physical association) | 0.000 |
| APPL1 | CIPC | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (27): CIPC (Two-hybrid), CIPC (Affinity Capture-RNA), CIPC (Affinity Capture-RNA), CLOCK (Two-hybrid), CSNK2B (Two-hybrid), DEC1 (Two-hybrid), RORC (Two-hybrid), CIPC (Affinity Capture-MS), ZMYM4 (Affinity Capture-MS), CLOCK (Affinity Capture-MS), CIPC (Affinity Capture-MS), CLOCK (Affinity Capture-MS), CIPC (Affinity Capture-MS), ZMYM4 (Affinity Capture-MS), CIPC (Two-hybrid)
ESM2 similar proteins: A0P8Z5, B0KYV5, B1WC58, B2RYR0, F1LR10, F6SNN2, O75128, O75410, P51826, P61590, P61591, P61592, P61593, P61594, Q3USH1, Q501R9, Q5IFK1, Q5PQK4, Q5R8C5, Q5SU73, Q5SWA1, Q5U5Q9, Q6NZF1, Q6P1D7, Q6P7W0, Q6PJW8, Q6Y685, Q6ZSG2, Q6ZVT6, Q7TT79, Q80XI1, Q80XJ2, Q80YR6, Q86T90, Q8BFU3, Q8C9B9, Q8IY92, Q8IYW5, Q8ND24, Q8NEM0
Diamond homologs: Q5R8C5, Q6NRH7, Q8R0W1, Q9C0C6
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
61 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 59 |
| Likely benign | 2 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
709 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 14:77105656:GGGCA:G | acceptor_gain | 1.0000 |
| 14:77105829:G:GT | donor_gain | 1.0000 |
| 14:77098355:GCCC:G | donor_gain | 0.9900 |
| 14:77105653:ATAG:A | acceptor_gain | 0.9900 |
| 14:77105815:C:G | donor_gain | 0.9900 |
| 14:77105842:CAG:C | donor_loss | 0.9900 |
| 14:77105843:AG:A | donor_loss | 0.9900 |
| 14:77105844:G:GC | donor_loss | 0.9900 |
| 14:77105844:GG:G | donor_loss | 0.9900 |
| 14:77105845:GTT:G | donor_loss | 0.9900 |
| 14:77098360:AGGTG:A | donor_loss | 0.9800 |
| 14:77098361:GGTGA:G | donor_loss | 0.9800 |
| 14:77098362:GTG:G | donor_loss | 0.9800 |
| 14:77098363:T:A | donor_loss | 0.9800 |
| 14:77098363:T:G | donor_loss | 0.9800 |
| 14:77098371:G:GT | donor_gain | 0.9800 |
| 14:77098372:G:T | donor_gain | 0.9800 |
| 14:77105652:CATA:C | acceptor_loss | 0.9800 |
| 14:77105654:T:G | acceptor_gain | 0.9800 |
| 14:77105655:A:AC | acceptor_loss | 0.9800 |
| 14:77105655:A:AG | acceptor_gain | 0.9800 |
| 14:77105656:G:GG | acceptor_gain | 0.9800 |
| 14:77105846:T:G | donor_gain | 0.9800 |
| 14:77106245:ATACT:A | donor_gain | 0.9800 |
| 14:77105655:AG:A | acceptor_gain | 0.9600 |
| 14:77105656:GG:G | acceptor_gain | 0.9600 |
| 14:77105760:G:GG | donor_gain | 0.9600 |
| 14:77109806:CACCA:C | acceptor_loss | 0.9600 |
| 14:77109807:ACCAG:A | acceptor_loss | 0.9600 |
| 14:77109808:CCA:C | acceptor_loss | 0.9600 |
AlphaMissense
2595 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 14:77114089:T:C | L324P | 0.999 |
| 14:77114104:T:C | L329S | 0.999 |
| 14:77114176:T:C | L353P | 0.999 |
| 14:77114068:T:C | F317S | 0.998 |
| 14:77114089:T:A | L324Q | 0.998 |
| 14:77114097:T:C | S327P | 0.998 |
| 14:77114134:T:C | L339S | 0.998 |
| 14:77105838:T:C | F44L | 0.997 |
| 14:77105840:T:A | F44L | 0.997 |
| 14:77105840:T:G | F44L | 0.997 |
| 14:77114101:G:T | G328V | 0.997 |
| 14:77114205:G:C | A363P | 0.997 |
| 14:77114107:T:C | L330P | 0.996 |
| 14:77114067:T:C | F317L | 0.995 |
| 14:77114069:T:A | F317L | 0.995 |
| 14:77114069:T:G | F317L | 0.995 |
| 14:77114086:T:A | V323D | 0.995 |
| 14:77114113:T:C | I332T | 0.995 |
| 14:77114113:T:G | I332S | 0.995 |
| 14:77114143:A:C | Q342P | 0.995 |
| 14:77114167:T:C | L350P | 0.995 |
| 14:77114074:A:T | N319I | 0.994 |
| 14:77114080:T:C | L321P | 0.994 |
| 14:77114089:T:G | L324R | 0.993 |
| 14:77114104:T:G | L329W | 0.992 |
| 14:77114242:T:C | L375P | 0.992 |
| 14:77113609:C:A | A164D | 0.991 |
| 14:77114068:T:G | F317C | 0.991 |
| 14:77113585:T:C | I156T | 0.990 |
| 14:77114064:C:A | R316S | 0.990 |
dbSNP variants (sampled 300 via entrez): RS1000989953 (14:77106778 T>C), RS1001085758 (14:77115608 A>G), RS1001107859 (14:77101766 C>T), RS1001449272 (14:77116738 G>A), RS1001482400 (14:77104941 TCA>T), RS1001506814 (14:77102742 C>A,T), RS1001598403 (14:77105252 C>G), RS1002106176 (14:77096313 C>T), RS1002455357 (14:77115245 T>G), RS1002875250 (14:77115651 A>G), RS1002903036 (14:77100457 G>T), RS1003128160 (14:77103930 C>A,T), RS1003274383 (14:77103799 G>A), RS1003340082 (14:77097751 C>A,T), RS1003396959 (14:77104292 G>A)
Disease associations
OMIM: gene MIM:616995 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
3 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST008759_16 | Intake of total sugars | 4.000000e-06 |
| GCST90011898_25 | Alanine aminotransferase levels | 3.000000e-08 |
| GCST90011899_24 | Aspartate aminotransferase levels | 3.000000e-09 |
EFO canonical traits (2, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0010158 | sugar consumption measurement |
| EFO:0004736 | aspartate aminotransferase measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
20 total (human), top 20 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Smoke | increases expression, decreases expression, increases abundance | 2 |
| sodium arsenite | decreases expression | 1 |
| abrine | decreases expression | 1 |
| Resveratrol | affects cotreatment, increases expression | 1 |
| Air Pollutants | increases abundance, increases expression | 1 |
| Arsenic | affects methylation | 1 |
| Benzo(a)pyrene | increases expression | 1 |
| Carbamazepine | affects expression | 1 |
| Cisplatin | increases expression | 1 |
| Doxorubicin | decreases expression | 1 |
| Hydrogen Peroxide | increases expression | 1 |
| Plant Extracts | affects cotreatment, increases expression | 1 |
| Quercetin | decreases expression | 1 |
| Thiram | decreases expression | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
| Urethane | decreases expression | 1 |
| Valproic Acid | affects expression | 1 |
| Cyclosporine | increases expression | 1 |
| Cadmium Chloride | decreases expression | 1 |
| Copper Sulfate | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.